Strolll
Strolll is a UK digital health company that delivers an augmented reality neurorehabilitation platform via AR glasses, providing gait training, rehab exercises, and assessments for patients with Parkinson's, stroke, and Multiple Sclerosis in clinical and community settings.
- Company typePrivate
- Founded2018
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Strolll does
Strolll is a UK-headquartered digital health company that has built an augmented reality (AR) neurorehabilitation platform for patients with neurological conditions, principally Parkinson's disease, stroke, and Multiple Sclerosis. The platform is delivered through AR glasses that overlay personalised visual cueing and therapeutic exercises onto the real-world environment, supporting gait training, motor rehabilitation, balance exercises, and cognitive tasks across the full mobility spectrum from bedside (supine/seated) through standing and walking. Two trademarked systems anchor the offering — NAVIGAIT (gait training) and REALITY DTX (digital therapeutics) — and the software is complemented by a web-based portal for clinical data management. The platform unifies three modules — Rehab Exercises, Gait Training, and Assessments — into a single clinician-facing system designed to fit into existing therapy workflows with minimal setup.
Commercially, Strolll monetises through device rental of AR hardware paired with annual software licensing, sold via enterprise field sales to hospitals, outpatient rehabilitation clinics, NHS trusts, and more recently community leisure operators. The company targets three primary use-case segments: inpatient neurological rehabilitation, outpatient rehabilitation clinics, and home/community care, with Parkinson's, stroke, and MS as the core indications. Distribution is direct, with no public pricing disclosed. The company was founded in 2018 in Stafford, UK, and has since opened a US subsidiary (Strolll Inc.) in Cleveland, Ohio, anchored by a strategic collaboration with Cleveland Clinic that included IP transfer and an equity investment.
Strolll has raised approximately £12.5 million across seed (£2.1M in October 2023 led by Midven) and Series A (£10.4M / €12.2M in March 2025 led by IW Capital), with additional participation from the EIC Accelerator, SFC Capital, Cleveland Clinic, and Propel@YH across earlier and bridge rounds. Headcount sits in the 11–50 range. The company remains privately held with no public revenue disclosures, and its commercial footprint currently rests on a limited set of named enterprise customers (Cleveland Clinic, Wave Active Health, named NHS pilots and individual clinicians), implying an early-commercial stage with concentration risk and limited revenue predictability at present.
Strolll firmographics
Firmographics- Name
- Strolll
- Legal name
- Strolll Ltd
- Website
- https://strolll.co
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Strolll is a UK digital health company that delivers an augmented reality neurorehabilitation platform via AR glasses, providing gait training, rehab exercises, and assessments for patients with Parkinson's, stroke, and Multiple Sclerosis in clinical and community settings.
- Ownership category
- akta.pro rank
Strolll industry classification
Industry- Product category
- Digital Therapeutics / Neurorehabilitation Software
- NAICS
- Services for the Elderly and Persons with Disabilities (62412)
- SIC
- Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- AR-Guided Learning & On-the-Job Performance Support (Step-by-Step Overlays) (EDAFAJAF)
Keywords
Where Strolll is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Strolll business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Device Rental: AR glasses hardware rental as part of service delivery model, making the technology accessible without requiring upfront capital purchase.
- Software Access: Licensed access to proprietary Strolll software platform including NAVIGAIT and REALITY DTX digital therapeutics modules, provided as a limited non-exclusive license.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Device rental and software access model |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Strolll product offering
Product offeringCore offering
Strolll develops and sells an augmented reality (AR) neurorehabilitation platform delivered through AR glasses that overlays visual cueing and therapeutic exercises onto the real-world environment. The platform combines gait training, rehab exercises, and assessments in one system to help clinicians deliver engaging therapy for neurological conditions including Parkinson's disease, stroke, and Multiple Sclerosis. The company offers the solution as a bundled device-rental and software-access subscription sold to healthcare providers and rehabilitation settings.
Product overview
Strolll offers a unified augmented reality neurorehabilitation platform designed to help clinicians deliver engaging, high-intensity therapy for patients with neurological conditions such as Parkinson's, stroke, and Multiple Sclerosis. The platform integrates three core modules—Rehab Exercises, Gait Training, and Assessments—alongside a web-based portal for data management. Using AR glasses that overlay visual cueing onto the real-world environment, the system enables therapy delivery from bedside to home settings across inpatient, outpatient, and home care settings.
Differentiator
Problem solved
Functional benefit
Products and services
- Strolll Platform Augmented reality neurorehabilitation platform that overlays visual cueing and therapeutic exercises onto the real-world environment, delivered through AR glasses, to help clinicians deliver engaging, high-intensity therapy for patients with neurological conditions such as Parkinson's, stroke, and Multiple Sclerosis across inpatient, outpatient, community, and home settings.
- NAVIGAIT Proprietary AR-based gait training and mobility solution that provides consistent visual cueing to help patients with neurological conditions improve walking and movement, removing the need for manual floor markers.
- REALITY DTX Trademarked digital therapeutics system for neurorehabilitation that enables clinicians to deliver engaging therapy sessions using AR-guided exercises for motor, balance, and cognitive tasks.
Quantifiable outcome
- Patient testimonials report improvements in walking, balance and stamina
- +1 more outcomes
Companies that use Strolll
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Strolll technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Strolll partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and core.
- Wave Active HealthflagshipWave Active Health operates the Downs Leisure Centre in Seaford, East Sussex, where Strolll AR glasses were deployed in a specialist health and rehabilitation suite. This marks the first deployment of Strolll technology outside a clinical setting in the UK, representing a flagship implementation in the community health space.
- Cleveland CliniccoreCleveland Clinic collaboration marks Strolll’s US market entry. The partnership involved IP transfer from Cleveland Clinic to Strolll, with Cleveland Clinic becoming a shareholder. This strategic alliance provides clinical validation, regulatory pathway support, and distribution leverage within the US healthcare system.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Strolll competitors and assessment
Company assessmentBroad incumbents
- Saebo: Saebo is an established neurorehabilitation product company selling upper-limb devices and therapy programs to clinicians and patients globally, serving as a broader incumbent in the same neurological rehab category.
Direct peers
- MindMaze: MindMaze develops digital neurotherapeutics using VR/AR for stroke, brain injury, and Parkinson's rehabilitation, overlapping directly with Strolll's neurological condition focus and AR-enabled therapy delivery to hospitals and rehab clinics.
- Penumbra (REAL System): Penumbra's REAL Immersive System is an FDA-cleared VR platform for rehabilitation of stroke and other neurological conditions, making it a directly comparable immersive neuro rehab competitor sold into US hospitals.
- XRHealth: XRHealth operates a VR-based telehealth therapy platform covering neurological, orthopedic, and cognitive conditions, directly competing for the same clinician and patient population Strolll targets.
- MedRhythms: MedRhythms builds digital therapeutics for neurologic conditions (notably stroke gait and mobility), competing in the same digital neuro-rehabilitation category as Strolll with prescribed software products.
- Constant Therapy Health: Constant Therapy Health provides a digital neuro-rehabilitation platform for speech, language, and cognitive therapy used by clinicians and patients at home, overlapping on the digital neuro rehab go-to-market and care continuum.
Emerging players
- Neuro Rehab VR: Neuro Rehab VR develops VR-based gamified exercises for physical, occupational, and speech therapy, addressing neurological recovery in clinical settings with a similar but VR-first approach.
- Flint Rehab Devices: Flint Rehab produces rehabilitation devices and software (e.g., MusicGlove, FitMi) for stroke and neurological recovery, comparable in clinical use case and target clinician buyer though more device-led.
- Cionic: Cionic develops wearable assistive technology (Neural Sleeve) for mobility impairment from neurological conditions like MS, stroke, and Parkinson's, competing for the same patient population seeking gait and mobility improvement.
- Rehabtronics: Rehabtronics builds neurorehabilitation technologies including the ReJoyce and Prelivia systems for hand/arm rehabilitation and stroke recovery, overlapping on neurological rehab device sales to clinicians.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Strolll social profiles
Digital presenceStrolll financial estimates
Financial estimateRevenue estimate
Valuation estimate
Strolll leadership team
Management profileNumber of profiles
Profiles1 record
Strolll subsidiaries and ownership
Company hierarchySubsidiaries1 record
Strolll funding detail
Funding detailFunding overview
Funding rounds11 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Strolll M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Strolll
What does Strolll do?
Strolll develops and sells an augmented reality (AR) neurorehabilitation platform delivered through AR glasses that overlays visual cueing and therapeutic exercises onto the real-world environment. The platform combines gait training, rehab exercises, and assessments in one system to help clinicians deliver engaging therapy for neurological conditions including Parkinson's disease, stroke, and Multiple Sclerosis. The company offers the solution as a bundled device-rental and software-access subscription sold to healthcare providers and rehabilitation settings.
Is Strolll a public or private company?
Strolll is a private company. It is classified as venture growth investor backed and is currently operating.
When was Strolll founded?
Strolll was founded in 2018. It employs 11 to 50 people.
Where is Strolll based?
Strolll is headquartered in London, United Kingdom, in the Europe region.
How does Strolll make money?
Two revenue lines are on record. Device Rental is the primary driver. The others are software Access.
Who are Strolll's main competitors?
Saebo is listed as a broad incumbent. Direct peers are MindMaze, Penumbra (REAL System), XRHealth, MedRhythms and Constant Therapy Health. Emerging players are Neuro Rehab VR, Flint Rehab Devices, Cionic and Rehabtronics.
Does Strolll have an API?
No public API is recorded for Strolll.
What industry is Strolll in?
Strolll's product category is Digital Therapeutics / Neurorehabilitation Software. Its primary akta.pro industry code is EDAFAJAF, AR-Guided Learning & On-the-Job Performance Support (Step-by-Step Overlays). Its NAICS code is 62412 and its SIC code is 7373.